γ-Secretase: Substrates and inhibitors

Molecular Neurobiology

Volumn 26, Issue 1, 2002, Pages 81-95

  Rochette, Marjorie J ^a   Murphy, Michael Paul ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Amyloid protein precursor; ErbB4; Notch; Presenilin; secretase; secretase inhibitors

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPOXIDE; IBUPROFEN; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; NOTCH RECEPTOR; PRESENILIN PROTEIN; PROTEIN; PROTEIN INHIBITOR; PROTEIN IRE1; UNCLASSIFIED DRUG; UVOMORULIN;

ALZHEIMER DISEASE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; REVIEW;

EID: 0036700809     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/mn:26:1:081     Document Type: Review

References (113)

1. Hardy, J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20(4), 154-159.
2. Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81(2), 741-766.
3. Glenner, G. G. and Wong, C. W. (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135.
4. McGeer, P. L., Klegeris, A., Walker, D. G., Yasuhara, O. and McGeer, E. G. (1994) Pathological proteins in senile plaques. Tohoku J. Exp. Med. 174(3), 269-277.
5. Braak, H. and Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
6. Hardy, J. A. and Higgins, G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256(5054), 184-185.
7. Selkoe, D. J. (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8(11), 447-453.
8. Seubert, P., Oltersdorf, T., Lee, M. G., Barbour, R., Blomquist, C., Davis, D. L., et al. (1993) Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361, 260-263.
9. Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., and Lannfelt, L. (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1, 345-347.
10. Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991) Segregation of a missense mutation in the amyloid precursor gene with familial Alzheimer's disease. Nature 349, 704-706.
11. Murrell, J., Farlow, M., Ghetti, B., and Benson, M. D. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99.
12. Ancolio, K., Dumanchin, C., Barelli, H., Warter, J. M., Brice, A., Campion, D., et al. (1999) Unusual phenotypic alteration of β-amyloid precursor protein (βAPP) maturation by a new Val-715-> Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 96(7), 4119-4124.
13. Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., et al. (1991) Early-onset Alzheimer's Disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353, 844-846.
14. Eckman, C. B., Mehta, N. D., Crook, R., Pereztur, J., Prihar, G., Pfeiffer, E., et al. (1997) A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of Aβ42(43). Hum. Mol. Genet. 6(12), 2087-2089.
15. Kwok, J. B., Li, Q. X., Hallupp, M., Whyte, S., Ames, D., Beyreuther, K., et al. (2000) Novel Leu723Pro amyloid precursor protein mutation increases amyloid β42(43) peptide levels and induces apoptosis. Ann. Neurol. 47(2), 249-253.
16. Kumar-Singh, S., De Jonghe, C., Cruts, M., Kleinert, R., Wang, R., Mercken, M., et al. (2000) Nonfibrillar diffuse amyloid deposition due to a γ(42)-secretase site mutation points to an essential role for N-truncated Aβ(42) in Alzheimer's disease. Hum. Mol. Genet. 9(18), 2589-2598.
17. Cai, X.-D., Golde, T. E., and Younkin, S. G. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-517.
18. 717) mutants. Science 264, 1336-1340.
19. Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., et al. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced protofibril formation. Nat. Neurosci. 4(9), 887-893.
20. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
21. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., et al. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274(5284), 99-102.
22. Lewis, J., Dickson, D. W., Lin., W. L., Chisholm, L., Corral, A., Jones, G., et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534), 1487-1491.
23. Gotz, J., Chen, F., van Dorpe, J. and Nitsch, R. M. (2001) Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Aβ42 fibrils. Science 293(5534), 1491-1495.
24. Vassar, R., Bennett, B., Babu-Khan, S., Rogers, G. and Citron, M. (1999) β-Secretase celavage of Alzheimer's Amyloid Precursor Protein by the transmembrane aspartic protease BACE. Science 286(22), 735-740.
25. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., and Wong, P. C. (2001) BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat. Neurosci. 4(3), 233-234.
26. Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., et al. (2001) Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation. Nat. Neurosci. 4(3), 231-232.
27. Roberds, S. L., Anderson, J., Basi, G., Bienkowski, M. J., Branstetter, D. G., Chen, K. S. et al. (2001) BACE1 knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10(12), 1317-1324.
28. Yu, G., Chen, F., Levesque, G., Nishimura, M., Zhang, D. M., Levesque, L., et al. (1998) The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin. J. Biol. Chem. 273(26), 16470-16475.
29. Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., et al. (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and APP processing. Nature 407, 48-54.
30. De Strooper, B. and Annaert, W. (2001) Presenilins and the intramembrane proteolysis of proteins: facts and fiction. Nat. Cell. Biol. 3, E221-E225.
31. Esler, W. P. and Wolfe, M. S. (2001) A portrait of Alzheimer secretases-new features and familiar faces. Science 293(5534), 1449-1454.
32. Checler, F. (2001) The multiple paradoxes of presenilins. J. Neuroch. 76(6), 1621-1627.
33. Sisodia, S. S. and St. George Hyslop, P. H. (2002) γ-Secretase, Notch, Aβ and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3, 281-290.
34. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
35. Rogaev, E. I., Sherrington, R., Levesque, G., Ikeda, M., and St. George Hyslop, P. H. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
36. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., et al. (1995) Candidate gene for the Chromsome 1 Familial Alzheimer's Disease Locus. Science 269, 973-977.
37. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., et al. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2(8), 864-870.
38. De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., et al. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391(6665), 387-390.
39. Capell, A., Steiner, H., Romig, H., Keck, S., Baader, M., Grim, M. G., et al. (2000) Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch. Nat. Cell Biol. 2(4), 205-211.
40. Murphy, M. P., Uljon, S. J., Fraser, P. E., Fauq, A., Lookingbill, H. A., Findlay, K. A., et al. (2000) Presenilin 1 regulates pharmacologically distinct γ-secretase activities: implications for the role of presenilin in γ-secretase cleavage. J. Biol. Chem. 275(34), 26277-26284.
41. Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., and Selkoe, D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398(6727), 513-517.
42. Herreman, A., Serneels, L., Annaert, W., Collen, D., Schoonjans, L., and De Strooper, B. (2000) Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2(7), 461-462.
43. Zhang, Z., Nadeau, P., Song, W., Donoviel, D., Yuan, M., Bernstein, A., and Yankner, B. A. (2000) Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1. Nat. Cell Biol. 2(7), 463-465.
44. Armogida, M., Petit, A., Vincent, B., Scarzello, S., Alves da Costa, C., and Checler, F. (2001) Endogenous β-amyloid production in presenilin-deficient embryonic mouse fibroblasts. Nat. Cell Biol. 3, 1030-1033.
45. Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J., Trumbauer, M. E., et al. (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387(6630), 288-292.
46. Struhl, G. and Greenwald, I. (1999) Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398(6727), 522-525.
47. Ye, Y. H., Lukinova, N., and Fortini, M. E. (1999) Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398(6727), 525-529.
48. Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. USA 96(21), 11872-11877.
49. Van Gassen, G., Annaert, W., and Van Broeckhoven, C. (2000) Binding partners of Alzheimer's disease proteins: are they physiologically relevant? Neurobiol. Dis. 7(3), 135-151.
50. Katayama, T., Imaizumi, K., Sato, N., Miyoshi, K., Kudo, T., Hitomi, J., et al. (1999) Presenilin-1 mutations downregulate the signaling pathway of the unfolded-protein response. Nat. Cell Biol. 1(8), 479-485.
51. Niwa, M., Sidrauski, C., Kaufman, R. J., and Walter, P. (1999) A role for presenilin-1 in nuclear accumulation of Ire 1 fragments and induction of the mammalian unfolded protein response. Cell 99(7), 691-702.
52. Katayama, T., Imaizumi, K., Honda, A., Yoneda, T., Kudo, T., Takeda, K., et al. (2001) Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations. J. Biol. Chem. 276(46), 43446-43454.
53. Sato, N., Urano, F., Yoon Leem, J., Kim, S. H., Li, M., Donoviel, D., et al. (2000) Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression. Nat. Cell Biol. 2(12), 863-870.
54. Steiner, H., Winkler, E., Shearman, M. S., Prywes, R., and Haass, C. (2001) Endoproteolysis of the ER stress transducer ATF6 in the presence of functionally inactive presenilins. Neurobiol. Dis. 8(4), 717-722.
55. Baki, L., Marambaud, P., Efthimiopoulos, S., Georgakopoulos, A., Wen, P., Cui, W., et al. (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl. Acad. Sci. USA 98(5), 2381-2386.
56. Marambaud, P., Shioi, J., Serban, G., Georgakopoulos, A., Sarner, S., Nagy, V., et al. (2002) A presenilin-1/g-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21(8), 1948-1956.
57. Doerfler, P., Shearman, M. S., and Perlmutter, R. M. (2001) Presenilin-dependent γ-secretase activity modulates thymocyte development. Proc. Natl. Acad. Sci. USA 98(16), 9312-9317.
58. Hadland, B. K., Manley, N. R., Su, D., Longmore, G. D., Moore, C. L., Wolfe, M. S., et al. (2001) γ-secretase inhibitors repress thymocyte development. Proc. Natl. Acad. Sci. USA 98(13), 7487-7491.
59. Tanaka, S., Nakamura, S., Ueda, K., Kameyama, M., Shiojiri, S., Takahashi, Y., et al. (1988) Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer's disease. Biochem. Biophys. Res. Commun. 157(2), 472-479.
60. Golde, T. E., Estus, S. G., Usiak, M., Younkin, L. H., and Younkin, S. G. (1990) Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4, 253-267.
61. Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
62. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., et al. (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96(7), 3922-3927.
63. Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., et al. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273(43), 27765-27767.
64. Parkin, E. T., Trew, A., Christie, G., Faller, A., Mayer, R., Turner, A. J., and Hooper, N. M. (2002) Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotnesin converting enzyme, CD23, and pro-tumor necrosis factor-a, Biochemistry 41, 4972-4981.
65. Saitoh, T., Sundsmo, M., Roch, J.-M., Kimura, N., Cole, G., Schubert, D., et al. (1989) Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts. Cell 58, 615-622.
66. Schubert, D., Schroeder, R., LaCorbiere, M., Saitoh, T., and Cole, G. (1988) Amyloid β protein precursor is possibly a heparan sulfate proteoglycan core protein. Science 241, 223-226.
67. Barger, S. W. and Mattson, M. P. (1996) Participation of gene expression in the protection against amyloid β-peptide toxicity by the β-amyloid precursor protein. Ann. NY Acad. Sci. 777, 303-309.
68. Heber, S., Herms, J., Gajic, V., Hainfellner, J., Aguzzi, A., Rulicke, T., et al. (2000) Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20(21), 7951-7963.
69. Pinnix, I., Musunuru, U., Tun, H., Sridharan, A., Golde, T., Eckman, C., et al. (2001) A novel γ-secretase assay based on detection of the putative C-terminal fragment-γ of amyloid β protein precursor. J. Biol. Chem. 276(1), 481-487.
70. Wahrle, S., Das, P., Nyborg, A. C., McLendon, C., Shoji, M., Kawarabayashi, T., et al. (2002) Cholesterol dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9, 11-23.
71. Cupers, P., Orlans, I., Craessaerts, K., Annaert, W., and De Strooper, B. (2001) The amyloid precursor protein (APP)-cytoplasmic fragment generated by γ-secretase is rapidly degraded but distributes partially in anuclear fraction of neurones in culture. J. Neurochem. 78, 1168-1178.
72. Cao, X. and Sudhof, T. C. (2001) A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293(5527), 115-120.
73. Gao, Y. and Pimplikar, S. W. (2001) The γ-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc. Natl. Acad. Sci. USA 98(26), 14979-14984.
74. Kimberly, W. T., Zheng, J. B., Guenette, S. Y., and Selkoe, D. J. (2001) The intracellular domain of the β-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276(43), 40288-40292.
75. Leissring, M. A., Murphy, M. P., Mead, T. R., Akbari, Y., Sugarman, M. C., Jannatipour, M., et al. (2002) A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP. Proc. Natl. Acad. Sci. USA 99(7), 4697-4702.
76. Artavanis-Tsakonas, S., Rand, M. D., and Lake, R. J. (1999) Notch signaling: cell fate control and signal integration in development. Science 284, 770-776.
77. Logeat, F., Bessia, C., Brou, C., LeBail, O., Jarriault, S., Seidah, N. G., and Israel, A. (1998) The Notch 1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. Acad. Sci. USA 95(14), 8108-8112.
78. Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J. R., et al. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5(2), 207-216.
79. Mumm, J. S., Schroeter, E. H., Saxena, M. T., Griesemer, A., Tian, X., Pan, D. J., et al. (2000) A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of Notch1. Mol. Cell 5(2), 197-206.
80. Greenwald, I. (1998) Lin-12/Notch signaling-lessons from worms and flies. Genes Dev. 12, 1751-1762.
81. De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., et al. (1999) A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature 398(6727), 518-522.
82. Jarriault, S., Brou, C., Logeat, F., Schroeter, E. H., Kopan, R., and Israel, A. (1995) Signaling downstream of activated mammalian Notch. Nature 377, 355-358.
83. Junttila, T. T., Sundvall, M., Maatta, J. A., and Elenius, K. (2000) ErbB4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc. Med. 10(7), 304-310.
84. Vecchi, M. and Carpenter, G. (1997) Constitutive proteolysis of the ErbB4 receptor tyrosine kinase by a unique, sequential mechanism. J. Cell Biol. 139(4), 995-1003.
85. Ni, C.-Y., Murphy, M. P., Golde, T. E., and Carpenter, G. (2001) γ-Secretase mediated cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181.
86. Lee, H.-J., Jung, K.-M., Huang, Y. Z., Bennett, L. B., Lee, J. S., Mei, L., and Kim, T.-W. (2002) Presenilin-dependent γ-secretase-like intramembrane cleavage of ErbB4. J. Biol. Chem. 277, 6318-6323.
87. Yu, C., Kim, S. H., Ikeuchi, T., Xu, H., Gasparini, L., Wang, R., and Sisodia, S. S. (2001) Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment γ: evidence for distinct mechansims involved in γ-secretase processing of the APP and Notch 1 transmembrane domains. J. Biol. Chem. 276(47), 43756-43760.
88. Sastre, M., Steiner, H., Fuchs, K., Capell, A., Multhaup, G., Condron, M. M., et al. (2001) Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2(9), 835-841.
89. Gu, Y., Misonou, H., Sato, T., Dohmae, N., Takio, K., and Ihara, Y. (2001) Distinct intramembrane cleavage of the β-amyloid precursor protein family resembling γ-secretase-like cleavage of Notch. J. Biol. Chem. 276(38), 35235-35238.
90. Zhang, J., Ye, W., Wang, R., Wolfe, M. S., Greenberg, B. D. and Selkoe, D. J. (2002) Proteolysis of chimeric β-amyloid precursor proteins containing the Notch transmembrane domain yields amyloid β-like peptides. J. Biol. Chem. 277(17), 15069-15075.
91. Brown, M. S., Ye, J., Rawson, R. B., and Goldstein, J. L. (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398.
92. Ye, J., Dave, U. P., Grishin, N. V., Goldstein, J. L., and M. S. Brown (2000) Asparagine-proline sequence within membrane-spanning segment of SREBP triggers intramembrane cleavage by site-2 protease. Proc. Natl. Acad. Sci. USA 97(10), 5123-5128.
93. Murphy, M. P., Hickman, L. J., Eckman, C. B., Uljon, S. N., Wang, R., and Golde, T. E. (1999) γ-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid β peptides of varying length. J. Biol. Chem. 274(17), 11914-11923.
94. Annaert, W. G., Esselens, C., Baert, V., Boeve, C., Snellings, G., Cupers, P., et al. (2001) Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32, 579-589.
95. Wolfe, M. S., Xia, W. M., Moore, C. L., Leatherwood, D. D., Ostaszewski, B., Rahmati, T., et al. (1999) Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry 38(15), 4720-4727.
96. Li, Y. M., Xu, M., Lai, M. T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., et al. (2000) Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405(6787), 689-694.
97. Seiffert, D., Bradley, J. D., Rominger, C. M., Rominger, D. H., Yang, F., Meredith, J. E., et al. (2000) Presenilin-1 and -2 are molecular targets for γ-secretase inhibitors. J. Biol. Chem. 275(44), 34086-34091.
98. Dovey, H. F., John, V., Anderson, J. P., Chen, L. Z., de Saint Andrieu, P., Fang, L. Y., et al. (2001) Functional γ-secretase inhibitors reduce β-amyloid peptide levels in brain. J. Neurochem. 76(1), 173-181.
99. Higaki, J. N., Chakravarty, S., Bryant, C. M., Cowart, L. R., Harden, P., Scardina, J. M., et al. (1999) A combinatorial approach to the identification of dipeptide aldehyde inhibitors of β-amyloid production. J. Med. Chem. 42(19), 3889-3898.
100. Klafki, H., Abramowski, D., Swoboda, R., Paganetti, P. A. and Staufenbiel, M. (1996) The carboxyl termini of β-amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities. J. Biol. Chem. 271(45), 28655-28659.
101. Yamazaki, T., Haass, C., Saido, T. C., Omura, S. and Ihara, Y. (1997) Specific increase in amyloid β-protein 42 secretion ratio by calpain inhibition. Biochemistry 36(27), 8377-8383.
102. Citron, M., Diehl, T. S., Gordon, G., Biere, A. L., Seubert, P. and Selkoe, D. J. (1996) Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93(23), 13170-13175.
103. McLendon, C., Xin, T., Ziani-Cherif, C., Murphy, M. P., Findlay, K. A., Lewis, P. A., et al. (2000) Cell-free assays for γ-secretase activity. FASEB J. 14(15), 2383-2386.
104. Wolfe, M. S., Citron, M., Diehl, T. S., Xia, W., Donkor, I. O. and Selkoe, D. J. (1998) A substrate-based difluoro ketone selectively inhibits Alzheimer's γ-secretase activity. J. Med. Chem. 41(1), 6-9.
105. Murphy, M. P., Wang, R., Fraser, P. E., Fauq, A., and Golde, T. E. (2000) An empirical model of γ-secretase activity. Ann. NY Acad. Sci. 920, 233-40.
106. Petit, A., Bihel, F., Alves da Costa, C., Pourquie, O., Checler, F. and Kraus, J. L. (2001) New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage. Nat. Cell Biol. 3(5), 507-511.
107. Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., et al. (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20(15), 5709-5714.
108. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., et al. (2001) A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414, 212-216.
109. Murphy, M. P., Uljon, S. N., Golde, T. E., and Wang, R. (2002) FAD-linked mutations in presenilin 1 after the length of Aβ peptides derived from βAPP transmembrane domain mutants. Biochim. Biophys. Acta 1586, 199-209.
110. Oster-Granite, M. L., McPhie, D. L., Greenan, J., and Neve, R. L. (1996) Age-dependent neuronal and synaptic degeneration in mice transgenic for the C-terminus of the amyloid precursor protein. J. Neurosci. 16(21), 6732-6741.
111. Sugarman, M. C., Yamasaki, T. R., Oddo, S., Echegoyan, J. C., Murphy, M. P., Golde, T. E., et al. (2002) Inclusion body myositis-like phenotype induced by transgenic overexpression of βAPP in skeletal muscle. Proc. Natl. Acad. Sci. USA 99(9), 6334-6339.
112. Golde, T. E. and Younkin, S. G. (2001) Presenilins as therapeutic targets for the treatment of Alzheimer's disease. Trends Mol. Med. 7(6), 264-269.
113. Murphy, M. P., Head, E., Cotman, C. W., and Golde, T. E. (2002) Developing therapeutic strategies to treat dementia in aged dogs, in Symposium on Brain Aging and Related Behavioral Changes in Dogs. Veterinary Healthcare Communications, (Huffaker, L., ed.) Lenexa, KS. Veterinary Medicine Part 2, pp. 10-12.